Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Practice Guidelines
    • Dermatology Guidelines
    • Safe and effective...

    Safe and effective prescribing of oral cyclosporine: British Association of Dermatologists Guidelines

    Written by Deepanjana Sarkar Published On 2019-10-02T19:00:58+05:30  |  Updated On 2 Oct 2019 7:00 PM IST
    Safe and effective prescribing of oral cyclosporine: British Association of Dermatologists Guidelines

    London--The British Association of Dermatologists has recently released guidelines aiming to provide up‐to‐date, evidence‐based recommendations for safe and effective use of oral cyclosporine in the field of dermatology. The guideline was published in the British Journal of Dermatology.


    Cyclosporin is an immunosuppressant primarily used during organ transplantation to stop host immune reaction. Recently it has grabbed the attention of dermatologists due to its effectiveness in treating psoriasis. Ciclosporin can reduce pain, swelling, and stiffness in rheumatoid arthritis. It’s also used to treat a number of other autoimmune and inflammatory diseases, including psoriatic arthritis and lupus.


    Read also: Cyclosporine quick and reliable treatment for atopic dermatitis in kids

    The drug is licensed only for the following indications




    • Severe atopic dermatitis (AD) (in persons aged 16 years or older)- For Atopic dermatitis, the recommended dosage range is 2·5–5 mg kg−1 per day given orally in single or divided (into two) doses for a maximum of 8 weeks.

    • Severe psoriasis (in persons aged 16 years or older)- For Psoriasis Vulgaris, the guideline recommends standard regimen which includes an initial dose for inducing remission of 2·5–5 mg kg−1 per day given orally, in a single dose or two divided doses. The higher initial dosage of 5 mg kg−1 per day can be given when rapid control is required. When time is less critical, a lower dose may be used initially and increased if the psoriasis is not clearly improving after 1 month.


    Read also: Atopic dermatitis patients are at increased long-term risk for AF

    Other than its effectiveness against Atopic dermatitis and Psoriasis there the guideline presented evidence that supported its use outside its product license. Following are the indications




    • Atopic dermatitis (in persons younger than 16 years)

    • Behçet disease

    • Chronic spontaneous (idiopathic) urticaria

    • Graft versus host disease

    • Palmoplantar pustulosis

    • Pyoderma gangrenosum


    The guideline recommends that cyclosporine should be used only as a last resort in the following indications, and current evidence shows it is unlikely to be beneficial:




    • Alopecia areata

    • Discoid lupus erythematosus

    • Pemphigus foliaceous

    • Pemphigus Vulgaris


    Read Also: Topical cyclosporine is new treatment for dry eye disease


    To read the full guideline, please follow the link https://doi.org/10.1111/bjd.17587


    Behçet diseaseBritish Association of DermatologistscyclosporineDermatologyimmune reactionimmunosuppressantinflammatory diseaselupusMedical newsoral cyclosporinorgan transplantationPemphigus foliaceouspsoriasispsoriatic arthritisrecommendationsrecommended dosagerheumatoid arthritis

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Deepanjana Sarkar
    Deepanjana Sarkar
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok